2,4-disubstituted pyrroles:: Synthesis, traceless linking and pharmacological investigations leading to the dopamine D4 receptor partial agonist FAUC 356
被引:26
作者:
Bergauer, M
论文数: 0引用数: 0
h-index: 0
机构:
Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, GermanyUniv Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
Bergauer, M
[1
]
Hübner, H
论文数: 0引用数: 0
h-index: 0
机构:
Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, GermanyUniv Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
Hübner, H
[1
]
Gmeiner, P
论文数: 0引用数: 0
h-index: 0
机构:
Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, GermanyUniv Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
Gmeiner, P
[1
]
机构:
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
Solution-phase synthesis and a solid-phase supported approach to piperazinylmethyl substituted pyrroles are described. Receptor binding studies and the measurement of D4 ligand efficacy led to the ethynylpyrrole 1d (FAUC 356) exerting selective D4 binding and substantial ligand efficacy (66%, EC50 = 1.9 nM). This activity profile might be of interest for the treatment of ADHD. (C) 2002 Elsevier Science Ltd. All rights reserved.